Targeting IL-33/ST2 signaling: regulation of immune function and analgesia (2017)
- Authors:
- USP affiliated authors: ALVES FILHO, JOSÉ CARLOS FARIAS - FMRP ; CUNHA, THIAGO MATTAR - FMRP ; CUNHA, FERNANDO DE QUEIROZ - FMRP
- Unidade: FMRP
- DOI: 10.1080/14728222.2017.1398734
- Subjects: DOR; INFLAMAÇÃO; DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO; NEURÔNIOS; ANALGESIA
- Keywords: Allodynia; MAPK; Glial cells; Hyperalgesia; Inflammatory pain; Neuropathy; Nociceptors; Pain therapy; Sensory neurons
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Expert Opinion on Therapeutic Targets
- ISSN: 1472-8222
- Volume/Número/Paginação/Ano: v. 21, n. 12, p. 1141-1152, 2017
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
FATTORI, Victor et al. Targeting IL-33/ST2 signaling: regulation of immune function and analgesia. Expert Opinion on Therapeutic Targets, v. 21, n. 12, p. 1141-1152, 2017Tradução . . Disponível em: https://doi.org/10.1080/14728222.2017.1398734. Acesso em: 29 mar. 2026. -
APA
Fattori, V., Hohmann, M. S. N., Rossaneis, A. C., Manchope, M. F., Alves Filho, J. C. F., Cunha, T. M., et al. (2017). Targeting IL-33/ST2 signaling: regulation of immune function and analgesia. Expert Opinion on Therapeutic Targets, 21( 12), 1141-1152. doi:10.1080/14728222.2017.1398734 -
NLM
Fattori V, Hohmann MSN, Rossaneis AC, Manchope MF, Alves Filho JCF, Cunha TM, Cunha F de Q, Verri WA. Targeting IL-33/ST2 signaling: regulation of immune function and analgesia [Internet]. Expert Opinion on Therapeutic Targets. 2017 ; 21( 12): 1141-1152.[citado 2026 mar. 29 ] Available from: https://doi.org/10.1080/14728222.2017.1398734 -
Vancouver
Fattori V, Hohmann MSN, Rossaneis AC, Manchope MF, Alves Filho JCF, Cunha TM, Cunha F de Q, Verri WA. Targeting IL-33/ST2 signaling: regulation of immune function and analgesia [Internet]. Expert Opinion on Therapeutic Targets. 2017 ; 21( 12): 1141-1152.[citado 2026 mar. 29 ] Available from: https://doi.org/10.1080/14728222.2017.1398734 - Pyrrolidine dithiocarbamate inhibits superoxide anion-induced pain and inflammation in the paw skin and spinal cord by targeting NF-kB and oxidative stress
- Toll like receptor 9 deficiency in neutrophil improves sepsis outcome preventing down-regulation of CXCR2
- Splenectomy increases neutrophil migration but does not affect mortality in lethal sepsis
- Probucol attenuates overt pain-like behavior and carrageenan-induced inflammatory hyperalgesia and leukocyte recruitment by inhibiting NF-кB activation and cytokine production without antioxidant effects
- Targeting nitric oxide as a key modulator of sepsis, arthritis and pain
- Curcumin inhibits superoxide anion-induced pain-like behavior and leukocyte recruitment by increasing Nrf2 expression and reducing NF-kB activation
- The citrus flavanone naringenin reduces gout-induced joint pain and inflammation in mice by inhibiting the activation of NFκB and macrophage release of IL-1β
- Pericytes modulate myelination in the central nervous system
- Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice
- The citrus flavonone naringenin reduces lipopolysaccharide-induced inflammatory pain and leukocyte recruitment by inhibiting NF-κB activation
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
